TGTX vs W · P/E 18, rev $240.3M vs rev $6.45B
TG Therapeutics Inc (TGTX) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Wayfair Inc (W) is a internet retail company listed on NYSE.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Latest reported W revenue for 2026-06-30 was $6.45B. Net income was -$106.0M. W currently screens at market cap $10.77B.
TGTX currently screens at market cap $7.88B and trailing P/E 18.0. W currently screens at market cap $10.77B.
Not investment advice. Open the TGTX and W stock pages for the full models.
Not investment advice.